|

Ipilimumab Injection Clinical Trials

2 actively recruiting trials across 1 location

No change since May 2026

Also known as: Atezolizumab, BMS-734016, Bevacizumab, MDX-CTLA4, MDX010

Pipeline

Phase 2: 1

Top Sponsors

  • Wu Wenming1
  • NYU Langone Health1

Indications

  • Cancer2
  • Unresectable Melanoma1
  • Pancreatic Cancer1
  • Melanoma1

Other1 trial

XH001 Combination With Immunocheckpoint Inhibitor and Chemotherapy for Patients With Resected Pancreatic Cancer
N/A

Los Angeles, California1 trial

Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma

The Angeles Clinic at Cedars Sinai

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.